Drug Profile
SR 11335
Latest Information Update: 18 May 2005
Price :
$50
*
At a glance
- Originator SRI International
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 18 May 2005 Discontinued - Preclinical for HIV-1 infections in USA (unspecified route)
- 24 Sep 1996 Suspended-Preclinical for HIV-1 infections in USA (Unknown route)